2021 annual financial data

Entrada Therapeutics 2021 Financial results

Direct answer

Revenue was 0 USD.

Operating income was -51,127,000 USD and net income was -50,072,000 USD.
Operating cash flow was -50,862,000 USD.

Get free Entrada Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
0 USD
Operating income
-51,127,000 USD
Net income
-50,072,000 USD
Operating cash flow
-50,862,000 USD